Overall, four primary biomarker clusters emerged: core Alzheimer’s disease pathology, neurodegeneration, AT8-associated tau phosphorylation and neuronal dysfunction and inflammation. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.